Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling

Xiuli Bi1, Yuqing Zhao, Wenfeng Fang

  • 1Department of Pathology, University of Illinois at Chicago, Chicago, Illinois 60612, USA.

Insights

A novel compound, PPD25, derived from Panax notoginseng, effectively inhibits cancer cell growth and promotes apoptosis. It targets the Wnt/beta-catenin pathway, showing potential for cancer prevention and therapy.

Area of Science:

  • Natural Products Chemistry
  • Molecular Biology
  • Cancer Research

Background:

  • The Wnt/beta-catenin pathway is crucial in cancer development.
  • Targeting this pathway offers potential for cancer prevention and treatment.
  • Natural products are a source of novel anticancer agents.

Purpose of the Study:

  • To investigate the anticancer activity of dammarane-type triterpene sapogenin (20(S)-25-OCH3-PPD; PPD25).
  • To evaluate PPD25's effects on colon and lung cancer cell lines.
  • To elucidate the molecular mechanisms underlying PPD25's anticancer effects.

Main Methods:

  • Anticancer activity was assessed in four cancer cell lines (3 colon, 1 lung).
  • Inhibition of cell proliferation and induction of apoptosis were measured.
  • Western blotting and reporter assays were used to study pathway modulation.

Main Results:

  • PPD25 significantly inhibited proliferation and induced apoptosis in all tested cancer cell lines.
  • PPD25 reduced the expression of beta-catenin and its downstream targets (c-myc, cyclin D1, cdk4, TCF-4).
  • PPD25 suppressed beta-catenin/TCF transcriptional activity.

Conclusions:

  • PPD25 exhibits anticancer properties by targeting the Wnt/beta-catenin signaling pathway.
  • PPD25 demonstrates potential as a chemotherapeutic or chemopreventive agent for colon and lung cancers.
  • Further research into PPD25 is warranted for cancer treatment strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...